Form D · Pharmaceuticals

Allegro Ophthalmics, LLC

San Juan Capistrano, CA · CIK 0001631466

Offering snapshot reported Oct 13, 2021 · SEC filing

Reported sold
$5.42M
Offering amount: $6.75M
Investors reported
6
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 3, 2021
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$2.71M$5.42MSep 10, 2021: $4,599,990.00Sep 10, 2021Oct 13, 2021: $5,423,284.00Oct 13, 2021

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$4,599,990 → $5,423,284

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 13, 2021Amendment$5,423,284$823,294vs Sep 10, 20216SEC filing
Sep 10, 2021Initial$4,599,990No comparisonNot reportedSEC filing
Oct 1, 2020Initial$8,324,042No comparison15SEC filing
Jan 30, 2020Amendment$5,335,973$335,973vs Dec 18, 201911SEC filing
Dec 18, 2019Initial$5,000,000No comparison1SEC filing
Jan 16, 2019Amendment$10,271,606$271,606vs Dec 21, 201814SEC filing
Dec 21, 2018Initial$10,000,000No comparison1SEC filing
Jul 10, 2017Initial$10,721,508No comparison17SEC filing
Jan 29, 2015Initial$20,328,214No comparison10SEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-412895
Convertible promissory notes and warrants, convertible into equity in a future financing

Source: Form D, filed Oct 13, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
A. Thomas Bender Director
Robert Byrnes Director
Marc Carlson Director
Rebecca Colbert Director
Scott Cooper Executive
Vicken Karageozian Director, Executive
Lisa Karageozian Director, Executive
Hampar Karageozian Director
Marc D. Kirshbaum Director, Executive
Ron Kurtz Director
Ronald Kurtz Director
William Link Director
Mark Livingston Director
John Park Director
Melvin Sarayba Executive
Stephanie Yee Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
31473 Rancho Viejo Road, Suite 204
San Juan Capistrano, CA, 92675